Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
Kanno
Mikiko
M
Department of Ophthalmology, School of Medicine, University of Tokyo, Japan.
Araie
Makoto
M
Masuda
Kanjiro
K
Takase
Masahiro
M
Kitazawa
Yoshiaki
Y
Shiose
Yoshihiko
Y
Azuma
Ikuo
I
Ogawa
Nobuya
N
Ohdo
Shigehiro
S
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004562:Electrocardiography; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000008:administration & dosage* / Q000627:therapeutic use*; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; D013999:Timolol; C036089:nipradilol